When evaluated in concert with cortical and hippocampal immunohistochemistry, these data further support a neuroprotective role of NLRP3 inhibition using VEN-02XX in neurodegenerative indications including AD pathology. This evidence concerns the gene NLRP3 and Alzheimer disease.